TFA Therapeutics annual current ratio
2021
2022
2023
2024
2025
TFA Therapeutics Current Ratio Growth & History (RAJAF)
TFA Therapeutics's current ratio was 0.19 for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.19 | 0.07 | +59.29% |
| 2024 | 2024-12-31 | 0.12 | 0.01 | +9.37% |
| 2023 | 2023-12-31 | 0.11 | −0.09 | −44.55% |
| 2022 | 2022-12-31 | 0.20 | −0.19 | −48.60% |
| 2021 | 2021-12-31 | 0.39 | — | — |
TFA Therapeutics quarterly current ratio
Q4.21
Q4.22
Q3.23
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.19 | 0.07 | +59.29% |
| Q4 2024 | 2024-12-31 | 0.12 | 0.01 | +9.37% |
| Q4 2023 | 2023-12-31 | 0.11 | −0.09 | −44.55% |
| Q3 2023 | 2023-09-30 | 0.04 | — | — |
| Q4 2022 | 2022-12-31 | 0.20 | −0.19 | −48.60% |
| Q4 2021 | 2021-12-31 | 0.39 | — | — |
TFA Therapeutics current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's current ratio decreased from 0.39 to 0.19, a change of −0.19. The latest reported quarter, Q4 2025, shows 0.19.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗